ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

38 hedge funds and large institutions have $11.2M invested in Oncternal Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less call options, than puts

Call options by funds: $ | Put options by funds: $

47% less capital invested

Capital invested by funds: $21M → $11.2M (-$9.88M)

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$19K
Puts
$29K
Net Calls
Net Calls Change

Top Buyers

1
+$129K
2
+$97K
3
+$71.3K
4
SIM
Spark Investment Management
New York
+$46K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$29K

Top Sellers

1
-$66K
2
-$32.6K
3
-$28K
4
OC
Oppenheimer & Co
New York
-$16K
5
BRWM
B. Riley Wealth Management
Tennessee
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$13K
27
$13K
28
$10K
29
$10K
30
$8K
31
$8K
32
$6K
33
$5K
34
$4K
35
$2K
36
$1K
37
$1K
38
$6
39
–
40
–
41
–
42
–
43
–
1
2